发明名称 Heteroaryl substituted biphenyl sulfonamides useful as dual angiotensin endothelin receptor antogonists
摘要 A biphenyl derivative or a salt thereof has the formula (I) wherein: R1 is substituted 5-oxo-imidazol-1-yl, 1-imidazol[4,5-b]pyridine, -N[C(=O)-R6][C(R9)(R7)H], 4-pyridinyloxy, 2-pyridinylamino, benzimidazol-1-yl, cycloheptimidazol-1-yl, 5,6,7,8-tetrahydro-4-quinolyloxy, 4-quinolyloxy, 1-pyrido[2,3-]pyridimine, 4-oxo-quinazol-1-yl, imidazol-1-yl, triazol-1-yl, or 1-pyrazolo[2,3-b]triazolyl; R2 is hydrogen, halogen, -CHO, alkyl, haloalkyl, (cycloalkyl)alkyl, alkenyl, alkynyl, alkoxyalkyl, haloalkoxyalkyl, alkoxy, alkoxyalkoxy, cyano, hydroxy, hydroxyalkyl, nitro, -CH(OR13)(OR14), -(CH2)Y with the proviso that when R1 is substituted 1-imidazol[4,5-b]pyridine, R2 is not hydrogen, halogen, alkyl, haloalkyl, alkoxy, hydroxyalkyl, nitro, -(CH2)wNR19R20 or NHSO2R22; R3 is heteroaryl and R6, R7, R9, R13, R14, w, R19 R20, R22 and Y are as defined in the specification. The compounds are useful in the treatment of acute or chronic renal failure, renal, glomerular or mesangial cell disorders, benign prostatic hypertrophy, subarachnoid hemorrhage, ischemica, asthma, migraine, cancer or hypertension.
申请公布号 NZ508118(A) 申请公布日期 2003.07.25
申请号 NZ19990508118 申请日期 1999.07.01
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 MURUGESAN, NATESAN;TELLEW, JOHN E;GU, ZHENGXIANG;MACOR, JOHN E
分类号 C07D233/70;A61K31/18;A61K31/415;A61K31/4162;A61K31/4178;A61K31/4184;A61K31/42;A61K31/422;A61K31/4245;A61K31/433;A61K31/437;A61K31/4418;A61K31/4427;A61K31/4439;A61K31/4709;A61K31/496;A61K31/497;A61K31/517;A61P3/00;A61P9/00;A61P9/02;A61P9/04;A61P9/10;A61P9/12;A61P11/06;A61P13/08;A61P13/12;A61P15/08;A61P15/10;A61P25/06;A61P35/00;A61P43/00;C07D211/72;C07D213/68;C07D215/16;C07D233/28;C07D235/02;C07D235/26;C07D239/72;C07D261/16;C07D401/12;C07D403/12;C07D403/14;C07D413/12;C07D413/14;C07D417/14;C07D471/04;C07D487/04;(IPC1-7):A61K31/422;A61K31/427;C07D401/14;C07D261/14;A61K31/424 主分类号 C07D233/70
代理机构 代理人
主权项
地址